NCT05413278 Targeted Interventions for Successful Transition and Transfer of Adolescents With Inborn Errors of Metabolism to Adult Services
| NCT ID | NCT05413278 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Children's Hospital, Zurich |
| Condition | Transition |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-01-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Main aims of this project are * To assess the baseline status-quo of transition and "fitness for transfer" in terms of information about the adult centre and team, organisational and practical skills (blood sampling and sending, how to make an appointment etc.), disease- and treatment-related knowledge, health-related quality of life (HrQoL), and self-efficacy in adolescnets with inborn errors of metabolism. Biochemical or physical parameters as appropriate for the respective diseases from 12 months before are documented. * To provide targeted, structured intervention modules (using available and, if necessary, adapted materials). * To measure the effects of these interventions on information about adult services short-term (within a month) and to re-assess all other baseline status-quo parameters long-term (6 and 12 months later). Psychological assessments will be complemented by biochemical or physical parameters as appropriate for the respective diseases and indicative for transition success.
Eligibility Criteria
Inclusion Criteria:Patients * with an inborn error of metabolism in the care of a specialized metabolic care unit * requiring specialized adult metabolic care * at least 14 years old * with a disease for which at least one biochemical and / or physical parameter disease marker is well established . Exclusion Criteria: Patients - * with insufficient knowledge of the German * with cognitive impairment to a degree that consent, and participation would be impossible * in an end-of-life situation * with a disease for which no biochemical and / or physical parameter disease marker is well established
Frequently Asked Questions
Who can join the NCT05413278 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 25 Years, studying Transition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05413278 currently recruiting?
Yes, NCT05413278 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Children's Hospital, Zurich to inquire about joining.
Where is the NCT05413278 trial being conducted?
This trial is being conducted at Vienna, Austria, Vienna, Austria, Basel, Switzerland, Basel, Switzerland and 4 additional locations.
Who is sponsoring the NCT05413278 clinical trial?
NCT05413278 is sponsored by University Children's Hospital, Zurich. The trial plans to enroll 20 participants.